Brain Tumors Moleculin Biotech Stock Is Trading Higher After WP1066 Scores Rare Pediatric Disease Tag For Type Of Brain Tumor benzinga.com - Vandana Singh read more
CNBCCathie Wood Cathie Wood sees these 2 trends as the next big things after electric vehicles verified_publisherCNBC - Maggie Fitzgerald Ark Invest's Cathie Wood said digital wallets and genomics are the next two biggest disruptive trends after Tesla and electric vehicles. "We're very …
Seeking AlphaMedical Conditions Fold gets back overweight rating from Canto on Pompe disease candidate verified_publisherSeeking Alpha - Dulan Lokuwithana, SA News Editor Amicus Therapeutics (FOLD +8.4%) is sharply higher today after Cantor Fitzgerald upgraded the stock to overweight from neutral with the unchanged …
NasdaqModerna's COVID-19 Shot Provides Over 90% Effectiveness Six Months After Second Dose, Boosters Can Potentially Fight Against... benzinga.com - Vandana Singh • Just a day before Moderna Inc’s (NASDAQ: MRNA) second annual Vaccines Day, the company has posted an update on its COVID-19 Vaccine Program, including …
The Motley FoolInvesting The Big Questions for Illumina After Its Q1 Sneak Peek and 2021 Guidance verified_publisherThe Motley Fool - Keith Speights and Brian Orelli, PhD The gene sequencing giant has a couple of key challenges going forward. Illumina (NASDAQ:ILMN) delivered a pleasant surprise earlier this month with …
TheStreetInvesting A Subscriber Asks About 2 Biotech ETFs and Here's What We Found TheStreet - Bruce Kamich A regular reader of Real Money emailed me about iShares Nasdaq Biotechnology (IBB) and SPDR S&P Biotech (XBI) - two biotech ETFs. "Wondered what you …
